Navigation Links
AHIP Statement on Daschle Nomination
Date:12/11/2008

WASHINGTON, Dec. 11 /PRNewswire-USNewswire/ -- Karen Ignagni, President and CEO of America's Health Insurance Plans (AHIP), today issued the following statement in response to the nomination of Senator Tom Daschle to be the next Secretary of the U.S. Department of Health and Human Services:

"The American people will welcome the nomination of Senator Tom Daschle because it signals that the incoming administration intends to prioritize comprehensive health care reform. Senator Daschle is exceptionally well qualified to bring people together in support of universal coverage, cost-containment, and improved quality."

AHIP's Board of Directors last week issued a comprehensive health care reform proposal to cover all Americans, reduce the growth of health care costs, and improve the quality and value of care. To learn more about AHIP's proposal, please visit www.americanhealthsolution.org.

America's Health Insurance Plans - Providing Health Benefits to More Than 200 Million Americans


'/>"/>
SOURCE America's Health Insurance Plans
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. New statement outlines essentials of heart failure clinics
2. United American Healthcare Corporation Issues Statement on Legal Motion Regarding Stock Repurchase Program
3. Statement on Nomination of Retired Gen. Eric Shinseki by VA Secretary Dr. James B. Peake
4. American Legion, Department of Indiana Releases Statement Concerning Revelations of Illicit Drug Trafficking at Roudebush VA Medical Center
5. Firearms Industry Statement on MN Dept of Agriculture Game Donation Testing
6. American Academy of Dermatology Issues Position Statement on Vitamin D
7. Statement of DNC Chairman Howard Dean on World AIDS Day
8. TFAH Statement: FDA Food Protection Plan is Insufficient
9. Assurant Comments on A.M. Best Ratings Statement; Ratings Continue to Reflect Assurants Solid Financial Position
10. International Formula Council Statement on Melamine and Infant Formulas
11. GPhA Statement on FTC Roundtable on Biogenerics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and athletic trainers ... say researchers presenting their work at the American Orthopaedic Society for Sports ... evaluating the patterns of change in concussion symptom presentation, diagnostic tools used and ...
(Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... IT operations analytics and application performance monitoring (APM) solutions, has expanded its ... services providers. , According to Peter Ohrenberger, sales director at Nastel, “We’ve ...
(Date:7/20/2017)... ... 20, 2017 , ... For individuals with extended hospital stays or who are ... such facilities are specially designed to accommodate patients with a wide range of ailments ... from Rochester, Ind., has invented the patent-pending PORTABLE ARM REST, a specially designed armrest ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... Team Type ... access to medicine for everyone affected by diabetes, is teaming up with a Microsoft ... global event kicks off on July 24th. , “Team Type 1’s mission overlaps ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)...  Dr. Echenberg, founder of Echenberg Institute, is announcing a new safe ... from painful intercourse and other painful pelvic pain conditions such as pelvic ... ... ... Florida -based start-up company, VuVatech LLC, fills a void in the ...
(Date:7/10/2017)... GAITHERSBURG, Md. , July 10, 2017 ... in non-animal test methods, is the recipient of a ... by the PETA International Science Consortium. The device, which ... be used to expose human lung cells to airborne ... lung. IIVS will use the VITROCELL® system for testing ...
(Date:7/10/2017)... , July 10, 2017 Locus Biosciences ... Note to support the development of CRISPR-Cas3 antimicrobial therapeutics. ... Limited, a leading Chinese Internet services provider, and joined ... advance multiple infectious disease product programs targeting antibiotic resistant ... Founded by Dr. Rodolphe Barrangou ...
Breaking Medicine Technology: